LA | |
---|---|
Post | - |
Pre | - |
M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | - | - | - | - | - | - | - | - | - | - | - |
1 | - | - | - | - | - | 2.0 | 26.0 | - | - | - | 28.0 |
LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
---|---|---|---|---|---|---|---|---|
Post | - | - | - | - | - | - | - | - |
Pre | - | - | - | - | - | - | - | - |
AME | |
---|---|
0 | 23 |
1 | 183 |
LOP1 | LOP2 | LOP3 | LOP4 | Total | |
---|---|---|---|---|---|
Post | - | - | - | - | - |
Pre | - | - | - | - | - |
central brain | |
---|---|
0 | 193 |
1 | 223 |
Number of post synapses: 0
Number of pre synapses: 28
Number of output connections: 110
Coverage factor: 1.0
Columnar completeness: 0.00
Area completeness: 0.00
Cell size (columns): 4
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
instance | NT | total connections | connections /#aMe10 (L) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | aMe5 (R) | ACh | 14 | 14.0 | 48.3% | 48.3% |
1 | aMe1 (R) | GABA | 6 | 6.0 | 20.7% | 69.0% |
2 | aMe4 (R) | ACh | 2 | 2.0 | 6.9% | 75.9% |
3 | MeVPaMe2 (L) | Glu | 2 | 2.0 | 6.9% | 82.8% |
4 | MeVPMe6 (L) | Glu | 2 | 2.0 | 6.9% | 89.7% |
5 | 5thsLNv_LNd6 (R) | ACh | 1 | 1.0 | 3.4% | 93.1% |
6 | aMe12 (R) | ACh | 1 | 1.0 | 3.4% | 96.6% |
7 | HBeyelet (R) | His | 1 | 1.0 | 3.4% | 100.0% |
instance | NT | total connections | connections /#aMe10 (L) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | aMe4 (R) | ACh | 565 | 565.0 | 51.1% | 51.1% |
1 | MeVPaMe2 (R) | Glu | 91 | 91.0 | 8.2% | 59.4% |
2 | aMe10 (R) | ACh | 86 | 86.0 | 7.8% | 67.1% |
3 | aMe5 (R) | ACh | 83 | 83.0 | 7.5% | 74.7% |
4 | aMe1 (R) | GABA | 79 | 79.0 | 7.1% | 81.8% |
5 | aMe15 (R) | unclear | 54 | 54.0 | 4.9% | 86.7% |
6 | MeVPaMe2 (L) | Glu | 20 | 20.0 | 1.8% | 88.5% |
7 | aMe23 (R) | unclear | 14 | 14.0 | 1.3% | 89.8% |
8 | Cm30 (R) | GABA | 11 | 11.0 | 1.0% | 90.8% |
9 | MeVPMe12 (R) | ACh | 11 | 11.0 | 1.0% | 91.8% |
10 | aMe17b (R) | GABA | 10 | 10.0 | 0.9% | 92.7% |
11 | aMe20 (R) | unclear | 10 | 10.0 | 0.9% | 93.6% |
12 | aMe6b (R) | ACh | 10 | 10.0 | 0.9% | 94.5% |
13 | Cm24 (R) | Glu | 9 | 9.0 | 0.8% | 95.3% |
14 | PLP211 (R) | unclear | 7 | 7.0 | 0.6% | 95.9% |
15 | aMe25 (R) | unclear | 5 | 5.0 | 0.5% | 96.4% |
16 | Cm33 (R) | GABA | 5 | 5.0 | 0.5% | 96.8% |
17 | Lat2 (R) | unclear | 5 | 5.0 | 0.5% | 97.3% |
18 | MeVPMe11 (R) | Glu | 4 | 4.0 | 0.4% | 97.6% |
19 | Cm35 (R) | GABA | 3 | 3.0 | 0.3% | 97.9% |
20 | aMe24 (R) | unclear | 2 | 2.0 | 0.2% | 98.1% |
21 | aMe6a (R) | ACh | 2 | 2.0 | 0.2% | 98.3% |
22 | LoVP38 (R) | Glu | 2 | 2.0 | 0.2% | 98.5% |
23 | MeVP11 (R) | ACh | 2 | 2.0 | 0.2% | 98.6% |
24 | MeVPaMe1 (R) | ACh | 2 | 2.0 | 0.2% | 98.8% |
25 | MeVPMe12 (L) | ACh | 2 | 2.0 | 0.2% | 99.0% |
26 | SLP250 (R) | unclear | 2 | 2.0 | 0.2% | 99.2% |
27 | aMe22 (R) | Glu | 1 | 1.0 | 0.1% | 99.3% |
28 | CL125 (R) | unclear | 1 | 1.0 | 0.1% | 99.4% |
29 | Cm15 (R) | GABA | 1 | 1.0 | 0.1% | 99.5% |
30 | l-LNv (R) | unclear | 1 | 1.0 | 0.1% | 99.5% |
31 | MeVC20 (R) | Glu | 1 | 1.0 | 0.1% | 99.6% |
32 | MeVC23 (R) | Glu | 1 | 1.0 | 0.1% | 99.7% |
33 | MeVP6 (R) | Glu | 1 | 1.0 | 0.1% | 99.8% |
34 | SLP249 (R) | unclear | 1 | 1.0 | 0.1% | 99.9% |
35 | Tm30 (R) | GABA | 1 | 1.0 | 0.1% | 100.0% |